Article Data

  • Views 331
  • Dowloads 106

Original Research

Open Access

Leiomyosarcoma of the uterine corpus with ovarian metastases in a 28-year-old woman: case report

  • M. Vasiljevic1,*,
  • D. Stanojevic1
  • M. Djukic1
  • A. Hajric1

1University Clinic of Gynaecology and Obstetrics Narodni Front, Belgrade, Serbia

DOI: 10.12892/ejgo20080198 Vol.29,Issue 1,January 2008 pp.98-100

Published: 10 January 2008

*Corresponding Author(s): M. Vasiljevic E-mail: dmdnmvas@eunet.yu

Abstract

A case of invasive leiomyosarcoma of the uterine corpus with right ovarian metastases in a 28-year-old woman is presented. The patient was submitted to surgery including total abdominal hysterectomy with left salpingo-oophorectomy, dissection of the pelvic and paraaortal lymph nodes and fixation of the right ovary to the psoas muscle. Postoperative radiation therapy was applied. A year after treatment, the patient was well.

Keywords

Leiomyosarcoma uteri; Ovarian metastases; Hysterectomy

Cite and Share

M. Vasiljevic,D. Stanojevic,M. Djukic,A. Hajric. Leiomyosarcoma of the uterine corpus with ovarian metastases in a 28-year-old woman: case report. European Journal of Gynaecological Oncology. 2008. 29(1);98-100.

References

[1] Harlow B.L., Weiss N.S., Lofton S.: “The epidemiology of sarcomas of the uterus”. J.N.C.I., 1986, 76, 399.

[2] Silverberg S.G., Major F.J., Blessing J.A. et al.: “Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecologic Oncology Group pathologic study of 203 cases”. Int. J. Gynecol. Pathol., 1990, 9, 1.

[3] Quinn M.A., Anderson M.C., Coulter C.A.E., Souter W.P.: “Malignant disease of the uterus”. In: Shaw R.W., Soutter W.P., Stanston S.L. (eds.), Gynecology, 2nd edn. New York, Churchill Livingstone, 1997, 600.

[4] Berchuck A., Rubin S.C., Hoskins W.J., Saigo P,E., Pierce V.K., Lewis J.L. Jr.: “Treatment of uterine leiomyosarcoma”. Obstet. Gynecol., 1988, 71, 845.

[5] Morice P., Rodrigues A., Pautier P., Rey A., Camatte S., Atallah D. et al.: “Surgery for uterine sarcoma: review of the literature and recommendations for the standard surgical procedure”. Gynecol. Obstet. Fertil., 2003, 31, 147.

[6] Kohorn E.I., Schwartz P.E., Chambers J.T., Peschel A., Kapp D.S., Merino M.: “Adjuvant therapy in mixed mullerian tumors of the uterus”. Gynecol. Oncol., 1986, 23, 212.

[7] DiSaia P.J., Pecorelli S.: “Gynecological sarcomas”. Semin. Surg. Oncol., 1994, 10, 369.

[8] Lurain J.R.: “Uterine cancer”. In: Berek S.J., Adashi E.Y., Hillard P.A. (eds.), Novak’s Gynecology, 12th edn., Baltimore, Williams & Wilkins, 1996, 1094.

[9] El Husseiny G., Al Bareedy N., Mourad W.A., Mohamed G., Shoukri M., Subhi J., Ezzat A.: “Prognostic factors and treatment modalities in uterine sarcoma”. Am. J. Clin. Oncol., 2002, 25, 256.

[10] Singh A.M., Konjengbam R., Devi S.S., Devi N.P.: “Leiomyosarcoma of uterus - a case report”. J. Indian. Med. Assoc., 2006, 104, 142.

[11] Vardi J.R., Tovell H.M.M.: “Leiomyosarcoma of the uterus: clinicopathologic study”. Obstet. Gynecol., 1980, 56, 428.

[12] Van Dinh T.V., Woodruff J.D.: “Leiomyosarcoma of the uterus”. Am. J. Obstet. Gynecol., 1982, 144, 817.

[13] Leitao M.M., Sonoda Y., Brennan M.F., Barakat R.R., Chi D.S.: “Incidence of lymph node and ovarian metastases in leiomyosarcoma of the uterus”. Gynecol. Oncol., 2003, 91, 209.

[14] Moinfar F., Azodi M., Tavassoli F.A.: “Uterine sarcomas”. Pathology, 2007, 39, 55.

[15] Giuntoli R.L., Metzinger D.S., DiMarco C.S., Cha S.S., Sloan J.A., Keeney G.L., Gostout B.S.: “Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy”. Gynecol. Oncol., 2003, 89, 460.

[16] Evans H.L., Chawla S.P., Simpson C., Finn K.P.: “Smooth muscle neoplasms of the uterus other than ordinary leiomyoma: a study of 46 cases, with emphasis on diagnostic criteria and prognostic factors”. Cancer, 1988, 62, 2239.

[17] Olah K.S., Dunn J.A., Gee H.: “Leiomyosarcomas have a poorer prognosis than mixed mesodermal tumours when adjusting for known prognostic factors: the result of a retrospective study of 423 cases of uterine sarcoma”. Br. J. Obstet. Gynaecol., 1992, 99, 590.

[18] Dusenbery K.E., Potish R.A., Judson P.: “Limitations of adjuvant radiotherapy for uterine sarcomas spread beyond the uterus”. Gynecol. Oncol., 2004, 94, 191.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top